203 related articles for article (PubMed ID: 12524223)
21. Mechanical properties of mesenteric resistance arteries from Dahl salt-resistant and salt-sensitive rats: role of endothelin-1.
Intengan HD; Schiffrin EL
J Hypertens; 1998 Dec; 16(12 Pt 2):1907-12. PubMed ID: 9886876
[TBL] [Abstract][Full Text] [Related]
22. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy.
Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S5-8. PubMed ID: 8587458
[TBL] [Abstract][Full Text] [Related]
23. Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats.
Bae EH; Kim IJ; Ma SK; Kim SW
Hypertens Res; 2010 Mar; 33(3):255-62. PubMed ID: 20057489
[TBL] [Abstract][Full Text] [Related]
24. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
Giulumian AD; Pollock DM; Clarke N; Fuchs LC
Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation.
Koh EH; Kim MS; Park JY; Kim HS; Youn JY; Park HS; Youn JH; Lee KU
Diabetes; 2003 Sep; 52(9):2331-7. PubMed ID: 12941773
[TBL] [Abstract][Full Text] [Related]
26. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.
Li JS; Larivière R; Schiffrin EL
Hypertension; 1994 Aug; 24(2):183-8. PubMed ID: 8039842
[TBL] [Abstract][Full Text] [Related]
27. ET(A) receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats.
Park JB; Schiffrin EL
Hypertension; 2001 Jun; 37(6):1444-9. PubMed ID: 11408393
[TBL] [Abstract][Full Text] [Related]
28. Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats.
Deng LY; Schiffrin EL
Am J Physiol; 1992 Jun; 262(6 Pt 2):H1782-7. PubMed ID: 1621836
[TBL] [Abstract][Full Text] [Related]
29. Effects of PPAR-gamma ligands on vascular smooth muscle marker expression in hypertensive and normal arteries.
Atkins KB; Northcott CA; Watts SW; Brosius FC
Am J Physiol Heart Circ Physiol; 2005 Jan; 288(1):H235-43. PubMed ID: 15345487
[TBL] [Abstract][Full Text] [Related]
30. Effects of peroxisome proliferator-activated receptor-β activation in endothelin-dependent hypertension.
Zarzuelo MJ; Gómez-Guzmán M; Jiménez R; Quintela AM; Romero M; Sánchez M; Zarzuelo A; Tamargo J; Pérez-Vizcaíno F; Duarte J
Cardiovasc Res; 2013 Sep; 99(4):622-31. PubMed ID: 23752977
[TBL] [Abstract][Full Text] [Related]
31. Structure and function of small arteries in salt-induced hypertension: effects of chronic endothelin-subtype-A-receptor blockade.
d'Uscio LV; Barton M; Shaw S; Moreau P; Lüscher TF
Hypertension; 1997 Oct; 30(4):905-11. PubMed ID: 9336391
[TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats.
Sakai S; Miyauchi T; Irukayama-Tomobe Y; Ogata T; Goto K; Yamaguchi I
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():16S-20S. PubMed ID: 12193046
[TBL] [Abstract][Full Text] [Related]
33. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.
Watts SW; Fink GD; Northcott CA; Galligan JJ
Br J Pharmacol; 2002 Sep; 137(1):69-79. PubMed ID: 12183332
[TBL] [Abstract][Full Text] [Related]
34. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan.
Larivière R; Sventek P; Thibault G; Schiffrin EL
Can J Physiol Pharmacol; 1995 Mar; 73(3):390-8. PubMed ID: 7544236
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of peroxisome proliferator activator receptor-alpha and gamma ligands on intimal hyperplasia after balloon catheter-induced vascular injury in Zucker rats.
Desouza CV; Murthy SN; Diez J; Dunne B; Matta AS; Fonseca VA; McNamara DB
J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):297-305. PubMed ID: 14740079
[TBL] [Abstract][Full Text] [Related]
36. Cardiac microvasculature in DOCA-salt hypertensive rats : effect of endothelin ET(A) receptor antagonism.
Larouche I; Schiffrin EL
Hypertension; 1999 Oct; 34(4 Pt 2):795-801. PubMed ID: 10523363
[TBL] [Abstract][Full Text] [Related]
37. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
[TBL] [Abstract][Full Text] [Related]
38. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.
Carneiro FS; Nunes KP; Giachini FR; Lima VV; Carneiro ZN; Nogueira EF; Leite R; Ergul A; Rainey WE; Clinton Webb R; Tostes RC
J Sex Med; 2008 Dec; 5(12):2793-807. PubMed ID: 18823320
[TBL] [Abstract][Full Text] [Related]
39. Endothelium-specific GTP cyclohydrolase I overexpression attenuates blood pressure progression in salt-sensitive low-renin hypertension.
Du YH; Guan YY; Alp NJ; Channon KM; Chen AF
Circulation; 2008 Feb; 117(8):1045-54. PubMed ID: 18268143
[TBL] [Abstract][Full Text] [Related]
40. Impaired flow-induced arterial remodeling in DOCA-salt hypertensive rats.
Lemkens P; Nelissen J; Meens MJ; Fazzi GE; Janssen GJ; Debets JJ; Janssen BJ; Schiffers PM; De Mey JG
Hypertens Res; 2012 Nov; 35(11):1093-101. PubMed ID: 22786567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
